-
Lupin submits New Drug Application for Etanercept biosimilar in Japan
biospectrumasia
May 10, 2018
Pharma major Lupin announced that YL Biologics (YLB) – its JV with Yoshindo and Kyowa (Lupin’s Subsidiary) in Japan has submitted a New Drug Application for...
-
Lupin gets US FDA nod to market testosterone gel
expressbpd
April 19, 2018
Lupin has received tentative nod from the US health regulator to market its Testosterone gel 1.62 per cent.
-
Lupin receives EIR from USFDA for Pithampur facility
biospectrumasia
April 08, 2018
The inspection was conducted in July 2017
-
Lupin launches generic Lodosyn tabs in the US
expressbpd
March 27, 2018
The drug is used for the treatment of idiopathic Parkinson’s disease
-
Lupin launches generic Namenda XR capsules in the US
biospectrumasia
February 26, 2018
It is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type
-
Lupin launches generic Kapvay tabs in the US
financialexpress
February 11, 2018
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD)
-
Lupin Q3 net profit dips 65 pc to Rs 222 cr
financialexpress
February 07, 2018
Consolidated income from operations also declined to Rs 3,900.36 crore
-
Lupin gets FDA approval
expressbpd
January 11, 2018
Lupine announced that it has obtained the final approval of the US Food and Drug Administration (FDA) OELTAMIVIR phosphate capsules USP, 30 mg (base), 45 mg (base) and 75 mg (base)
-
FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards
biospace
November 17, 2017
Lupin Ltd., which makes generic antibiotics, antidepressants and heart medications for sale in the U.S., was warned by the Food and Drug Administration for repeatedly ignoring tests showing that pills made at two of its facilities didn’t meet quality stan
-
Lupin receives US FDA warning letters
expressbpd
November 08, 2017
Lupin’s formulation manufacturing facilities at Goa and Indore (Pithampur Unit II) has received warning letter from the US FDA.